在患有高风险复发/耐药古典霍奇金淋巴瘤的儿童中,固定低剂量尼沃卢马布和本达穆斯丁的组合治疗

Shyam Srinivasan1,2, Aditya Narayan1,2, Chetan Dhamne1,2

  • 1Department of Paediatric Oncology, Tata Memorial Hospital/ACTREC, Mumbai, India.

概括

尼沃卢马布和本达穆斯丁的组合在治疗儿科高风险古典霍奇金淋巴瘤方面表现出高效. 这种治疗实现了88%的完全响应率,为复发或耐药性疾病的年轻患者提供了显著的希望.

相关概念视频

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
268